As tumour cells in experimental CRC lose IL-6R expression and become susceptible to IL-6 trans-signalling via the soluble IL-6R,15 our findings underlined that Th9 cells may regulate tumour growth via IL-6 trans-signalling. The gene discussed is IL6R; the disease is colorectal carcinoma.